Joffe R T, Singer W
Mood Disorders Program, Clarke Institute of Psychiatry, Toronto, Ontario, Canada.
Acta Med Austriaca. 1992;19 Suppl 1:96-7.
We assessed the effect of treatment with the tricyclic antidepressant, desipramine, on peripheral thyroid hormone levels in 28 severely depressed patients. Only those whose depression responded showed a decrease in their thyroxine levels without alteration of other thyroid function tests. In a second study involving 38 depressed patients, we observed an increased response to antidepressant treatment with the addition of triiodothyronine but not equivalent doses of thyroxine (T4). The finding is consistent with the decreases in plasma T4 levels which accompany an antidepressant response to desipramine.
我们评估了三环类抗抑郁药地昔帕明治疗对28例重度抑郁症患者外周甲状腺激素水平的影响。只有那些抑郁症有反应的患者甲状腺素水平下降,而其他甲状腺功能测试无变化。在第二项涉及38例抑郁症患者的研究中,我们观察到添加三碘甲状腺原氨酸后对抗抑郁治疗的反应增加,但等量的甲状腺素(T4)则无此效果。这一发现与地昔帕明抗抑郁反应时血浆T4水平下降一致。